FR
Solutions
Consulting
Products
Lab'O
Contact us
FR
EN
Menu
Insights
Scientific communications
Scientific communications
SPUR as a predictor of admission and early readmission in patients living with Type 2 Diabetes
Scientific communications
SPUR™ Validation in COPD
Scientific communications
Usage of the SPUR™ Adherence Profiling Tool in depression and anxiety: Initial Findings
Scientific communications
SPUR™ Phase 2 UK Study: final results
Scientific communications
Understanding patients' health decisions: 13 behavioral drivers - Brochure
Scientific communications
SPUR™ Phase 2 French study: final results
Scientific communications
SPUR™ Phase 2 US study: final results
Scientific communications
SPUR™ Phase 2 UK study: interim results
Scientific communications
SPUR™ Phase 0 study: final results
Scientific communications
Inodiab study: improvement of type 2 diabetes patients’ adherence
Scientific communications
Behavioral theories behind the SPUR™ model
Scientific communications
Observia published in the Journal of the American Pharmacists Association
Accès plateformes
English
Français
English
Improve patients' lives
Solutions
Understand
Personalize
Engage
Improve
Consulting
Insight generation
Implementation support
Go-to-market strategies
Products
Lab'O
The Lab Bench
The Garage
Observia
Discover us
Purpose
Story
Join us
Get in touch
Contact us
Newsletter
Follow us
insights
News
Going further in patient understanding: Neurish enriches social listening solution with Observia's behavioral diagnostic tool SPUR
events
11
oct
Events
Observia at Reuters Pharma
Oct 11
st
2022 at 08h00
